What is the recommended dose of Benadryl (diphenhydramine) for treating hives in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benadryl (Diphenhydramine) Dosing for Hives

For adults with hives, diphenhydramine should be administered at 25-50 mg orally every 4-6 hours as needed, with a maximum of 300 mg in 24 hours. For children 6-12 years old, the recommended dose is 25 mg (10 mL) every 4-6 hours, while diphenhydramine should not be used in children under 6 years of age. 1

Adult Dosing

  • Standard dose: 25-50 mg (10-20 mL) orally every 4-6 hours
  • Maximum daily dose: No more than 6 doses (300 mg) in 24 hours
  • Duration of treatment: As needed for symptom control

Pediatric Dosing

  • Children 6-12 years: 25 mg (10 mL) every 4-6 hours
  • Children >12 years: Same as adult dosing (25-50 mg every 4-6 hours)
  • Children <6 years: Not recommended 1

Administration Considerations

Diphenhydramine can be administered in several ways for hives:

  • Oral route is most common for outpatient management
  • Intramuscular route may be considered in acute settings when rapid response is needed, though evidence suggests the onset of action advantage over newer antihistamines is not statistically significant 2
  • Intravenous route should be reserved for severe cases in emergency settings

Efficacy and Alternatives

While diphenhydramine is effective for acute urticaria, newer second-generation antihistamines may offer advantages:

  • Recent research shows intravenous cetirizine (10 mg) is non-inferior to intravenous diphenhydramine (50 mg) for acute urticaria with benefits of less sedation, fewer adverse events, and shorter treatment time 3
  • For chronic urticaria, non-sedating second-generation antihistamines like cetirizine, desloratadine, levocetirizine, and rupatadine are recommended as first-line treatments 4

Important Side Effects and Precautions

  • Sedation: Diphenhydramine commonly causes drowsiness and can impair cognitive and motor function
  • Anticholinergic effects: Dry mouth, blurred vision, urinary retention, constipation
  • Special populations:
    • Hepatic impairment: Should be avoided in severe liver disease due to sedating effects 5
    • Pregnancy: Best to avoid all antihistamines especially in first trimester; chlorphenamine is often chosen if antihistamine therapy is necessary due to its long safety record 5

Management Algorithm for Hives

  1. For mild to moderate acute hives:

    • Start with diphenhydramine 25-50 mg orally every 4-6 hours (adults)
    • Consider adding H2 antagonists for better symptom control 6
  2. For severe or persistent hives:

    • Consider higher dose of diphenhydramine (up to 50 mg per dose)
    • If inadequate response, consider switching to second-generation antihistamines
    • For refractory cases, consider short course of oral corticosteroids 5
  3. For anaphylaxis with hives:

    • Epinephrine is first-line treatment (0.01 mg/kg, max 0.5 mg IM)
    • Diphenhydramine should be used as adjunctive therapy (25-50 mg) for cutaneous symptoms only 7
    • Never delay epinephrine to administer antihistamines 7

Remember that while diphenhydramine is effective for acute hives, its sedating properties may limit its use, especially for daytime treatment or in patients who need to remain alert. Consider non-sedating alternatives for long-term management of chronic urticaria.

References

Research

Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2008

Research

H1-antihistamines for chronic spontaneous urticaria.

The Cochrane database of systematic reviews, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Histamine H2-receptor antagonists for urticaria.

The Cochrane database of systematic reviews, 2012

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.